1. BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression
   Qiong Wu et al, 2022, Oncogene CrossRef
2. Prediction of pathological response grading for esophageal squamous carcinoma after neoadjuvant chemoradiotherapy based on MRI imaging using PDX
   Jingzhen Shi et al, 2023, Frontiers in Oncology CrossRef
3. The role of JMJD2A in immune evasion and malignant behavior of esophageal squamous cell carcinoma
   Xiangyu Su et al, 2024, International Immunopharmacology CrossRef
4. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers
   Tianfeng Lan et al, 2021, Aging CrossRef
5. Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma
   Yubing Zhou et al, 2023, Frontiers of Medicine CrossRef
6. Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Tumor Growth by Inducing Mitochondrial Autophagy
   Yifei Xie et al, 2020, Frontiers in Oncology CrossRef
7. Combination curcumin and (−)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
   G Jin et al, 2017, Oncogenesis CrossRef
8. Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization
   Jianling Zou et al, 2018, Journal of Translational Medicine CrossRef
9. Clinical and translational advances in esophageal squamous cell carcinoma
   Zachary Wilmer Reichenbach et al, 2019, CrossRef
10. Establishment and evaluation of four different types of patient-derived xenograft models
    Xiaoqian Ji et al, 2017, Cancer Cell International CrossRef
11. Constitutive activated STAT3 is an essential regulator and therapeutic target in esophageal squamous cell carcinoma
    Fang Tian et al, 2017, Oncotarget CrossRef
12. Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway
    Yi Yang et al, 2017, Oncotarget CrossRef
13. Anlotinib Combined With Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma
    Jingzhen Shi et al, 2020, Frontiers in Oncology CrossRef
14. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study
    Yanan Jiang et al, 2018, Journal of Translational Medicine CrossRef
15. Tumor xenograft animal models for esophageal squamous cell carcinoma
    Nikki P. Lee et al, 2018, Journal of Biomedical Science CrossRef